The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - TG Therapeutics
Leadership - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
Travel, Accommodations, Expenses - TG Therapeutics
Tolerability and activity of chemo-free triplet combination of TGR-1202, ublituximab, and ibrutinib in patients with advanced CLL and NHL.
 
Loretta J. Nastoupil
Honoraria - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; Pharmacyclics; TG Therapeutics
Research Funding - Abbvie; Celgene; Janssen Biotech; TG Therapeutics
Travel, Accommodations, Expenses - Janssen Biotech
 
Matthew Alexander Lunning
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; Juno Therapeutics; Pharmacyclics; Seagen; TG Therapeutics
 
Julie Vose
Consulting or Advisory Role - Bio Connections
Research Funding - Acerta Pharma (Inst); Allos Therapeutics (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Incyte (Inst); Janssen Biotech (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Seagen (Inst)
 
Marshall T. Schreeder
Research Funding - TG Therapeutics
 
Tanya Siddiqi
Speakers' Bureau - Pharmacyclics; Seagen
 
Christopher Flowers
Consulting or Advisory Role - Bayer; Gilead Sciences; OptumRx; Seagen
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immune Design (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Gilead Sciences
 
Jonathon Brett Cohen
Consulting or Advisory Role - Abbvie; Celgene; Infinity Pharmaceuticals; Millennium; Novartis; Pharmacyclics; Seagen
Research Funding - Bristol-Myers Squibb; Janssen; Novartis; Takeda
 
Jan Andreas Burger
No Relationships to Disclose
 
William G. Wierda
Consulting or Advisory Role - Abbvie; Celgene; Emergent BioSolutions; Genentech/Roche; Genzyme; Gilead Sciences; GlaxoSmithKline/Novartis; Merck; Pharmacyclics; Sanofi
Research Funding - Abbvie; Acerta Pharma; Emergent BioSolutions; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics
 
Susan Mary O'Brien
Honoraria - Abbvie; Alexion Pharmaceuticals; Amgen; Aptose Biosciences; Astellas Pharma; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Pfizer; Pharmacyclics; ProNAi; Regeneron; Sunesis Pharmaceuticals; Vaniam Group
Consulting or Advisory Role - Abbvie/Genentech; Alexion Pharmaceuticals; Amgen; Amgen Astellas BioPharma; Aptose Biosciences; Celgene; CLL Global Research Foundation; GlaxoSmithKline; Janssen Oncology; Sunesis Pharmaceuticals; Vaniam Group
Research Funding - Acerta Pharma; Gilead Sciences; Pfizer; Pharmacyclics; ProNAI; Regeneron; TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Janssen; Janssen Oncology; Regeneron
 
Peter Sportelli
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
Travel, Accommodations, Expenses - TG Therapeutics
 
Hari P. Miskin
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
Travel, Accommodations, Expenses - TG Therapeutics
 
Michelle A Purdom
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
Travel, Accommodations, Expenses - TG Therapeutics
 
Michael S. Weiss
No Relationships to Disclose
 
Nathan Hale Fowler
Research Funding - TG Therapeutics